IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

TC Biopharm Holdings PLC

Q1 2025 vs Q2 2025

Comparing institutional holders between quarters

Quarters

Q2 2025Q1 2025Q4 2024Q3 2024
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile
Rhumbline Advisers
UNCHANGED
Shares173 from 173
Change0 (0%)
Value$34 ($0)
Filed 2025-08-12
Status
Rhumbline Advisers
UNCHANGED17317300%$34$34$02025-08-12
Showing 1 of 1 institutions